<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Biotronik on Bioecon</title><link>https://en.bioecon.ru/companies/biotronik/</link><description>Recent content in Biotronik on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Mon, 20 Jul 2026 16:36:42 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/companies/biotronik/index.xml" rel="self" type="application/rss+xml"/><item><title>Implantable biosensors for chronic disease</title><link>https://en.bioecon.ru/technology/implantable-biosensors-chronic-disease/</link><pubDate>Mon, 20 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/implantable-biosensors-chronic-disease/</guid><description>Surgically or subcutaneously implanted sensors that continuously monitor a chronic-disease parameter for months to years without an external wearable — implantable continuous glucose monitors and insertable cardiac monitors — distinct from external wearables and ingested/swallowed sensors: Senseonics&amp;rsquo; Eversense 365 in the US, Medtronic&amp;rsquo;s LINQ II and Boston Scientific&amp;rsquo;s LUX-Dx cardiac monitors in the US, Biotronik&amp;rsquo;s BIOMONITOR in Germany, and MicroPort in China.</description></item></channel></rss>